AI-generated summary
The authors ran a small split-face randomized pilot trial in 21 patients with postacne erythema, treating one side of the face with a 577-nm laser and leaving the other side untreated. They report that erythema index scores fell on both sides, with a larger reduction on the treated side, and that side effects were mild and brief. The authors describe the laser as a possible adjuvant treatment.
- Participants
- 21
- Who or what was studied
- 21 patients with postacne erythema
- Wavelengths
- 577 nm
- Limits stated in the abstract
- The abstract describes a small pilot study with no stated blinding, short follow-up, and no report of melanin index differences between sides.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 15 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Randomized controlled trial, Pilot study, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.